-
Women should not quit taking birth control pills just because theyre gaining weight, say researchers at Oregon Health & Science University.
Results of a study released Wednesday found no support for a common belief that oral contraceptives cause weight gain.
-
PHILADELPHIA, April 22, 2011 /PRNewswire-USNewswire/ -- The following release is being issued by law firms RodaNast, P.C.; Levin, Fishbein, Sedran & Berman and Feldman & Pinto:
According to two new studies published in the online edition of the British Medical Journal, Bayer's birth control pills Yaz and Yasmin, containing a new progestin drospirenone (DSRP), carry up to triple the risk of serious blood clots (known as venous thromboembolism) over traditional pills containing the progestin levonorgestrel (LNG).
-
The newest form of combined oral contraceptives has given birth to a mass tort.
Several lawsuits have been filed in federal court against Bayer Corp. over Yaz/Yasmin birth control pills, alleging that a new ingredient in this "fourth generation" contraceptive presents dangerous risks that the company failed to warn about.
-
VERMONT - When Vermont's colleges and universities seek the federal government's help in growing their student bodies, this probably isn't the kind of "growth" they're expecting. Tens of thousands of health clinics nationwide, including some student health centers on Vermont college campuses, have experienced a dramatic rise in the cost of birth control pills and other female contraceptives. The price hikes are the direct result of changes in the Medicaid rebate program included in the 2005 Deficit Reduction Act, which took effect January 1.
A lot of these kids don't have cars, and Planned Parenthood is about 10 miles away from here," she says. "So I think there's definitely an access issue here.
According to [Rebecca Hill], the Ring, which sold for $5 last year, would have increased ...
-
The image of a sexually active 11-year-old girl receiving birth control pills at school serves the purpose of selling newspapers and hyping broadcasts. It is not, however, a productive starting point in the debate over reproductive health services for middle school students.
When the city's health department approached the Portland School Committee with a plan to expand services at the King Middle School clinic, officials didn't have sixth-graders in mind. Their concern was primarily with a handful of eighth-graders, most of them 14 or older, who have reported themselves to be sexually active.
-
SAN FRANCISCO -- Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, issued today a list of answers to co...
-
SAN FRANCISCO -- Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, issued today a list of answers to co...
-
WASHINGTON - Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from safety regulators.
Research suggesting that newer birth control formulations are more likely to cause blood clots than older drugs has prompted the Food and Drug Administration to consider new safety measures in meetings later this week. The increased risk is slight but significant because blood clots can cause heart attacks, strokes and blockages in lungs or blood vessels, which can be fatal.
-
Defending birth control pill
Regarding "How birth control pills have harmed society" (Other Views, May 18):
-
The birth control pill Yaz and its generic counterpart Ocella were recalled back in November over quality issues at a Bayer factory in Germany, but neither the FDA nor Bayer publicized the recall.
The recall, buried in a FDA enforcement report, covers about 33,000 boxes of Yaz and 122,000 boxes of Ocella. The report states that the reason for the recall is that "out of specification" chemical values of drosperinone and ethinyl estradiol were averaged with other values to produce a value within specifications.